SectorBiological Technology
Established Date26/10/2015
Listing Date08/02/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees161
Fiscal Year Ends31/12
Security TypeCommon stock
Office address3115 Merryfield Row, Suite 120, San Diego, California 92121
Business
IntroductionGossamer Bio, Inc., was incorporated under the laws of the State of Delaware on October 26, 2015. The Company is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, including pulmonary hypertension and pulmonary hypertension associated with interstitial lung disease. It is led by a management team with extensive experience in leading biopharmaceutical companies.
